Illumina昨日在盘中遭遇大跌,股价下跌5.42%,引发了市场的广泛关注。分析人士认为,公司业绩持续走低可能是导致股价下跌的主要原因。
根据Illumina最近公布的财报数据,公司营收为43.72亿美元,同比下滑约10%;净利润则为-12.23亿美元,较上年同期的正数扭亏为负。每股收益为-7.69美元,较去年同期的2.36美元大幅下滑。公司毛利润为28.62亿美元,较去年同期小幅下降。
业绩持续下滑的背景下,Illumina股价面临着较大的压力。分析人士指出,虽然公司在基因测序和生命科学领域处于领先地位,但面临着激烈竞争和市场增长放缓的挑战。投资者对公司能否重新恢复盈利能力和增长动能存在疑虑,这可能是导致Illumina股价下跌的主要原因。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.